Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Change in Cash: 2020-2025

Historic Change in Cash for Caribou Biosciences (CRBU) over the last 5 years, with Sep 2025 value amounting to -$14.1 million.

  • Caribou Biosciences' Change in Cash fell 138.42% to -$14.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.8 million, marking a year-over-year increase of 71.11%. This contributed to the annual value of -$34.9 million for FY2024, which is 385.91% down from last year.
  • Caribou Biosciences' Change in Cash amounted to -$14.1 million in Q3 2025, which was down 233.42% from -$4.2 million recorded in Q2 2025.
  • Caribou Biosciences' Change in Cash's 5-year high stood at $305.8 million during Q3 2021, with a 5-year trough of -$194.9 million in Q4 2021.
  • Moreover, its 3-year median value for Change in Cash was -$5.6 million (2023), whereas its average is -$4.3 million.
  • The largest annual percentage gain for Caribou Biosciences' Change in Cash in the last 5 years was 3,662.69% (2021), contrasted with its biggest fall of 2,167.74% (2021).
  • Quarterly analysis of 5 years shows Caribou Biosciences' Change in Cash stood at -$194.9 million in 2021, then soared by 87.82% to -$23.7 million in 2022, then plummeted by 122.75% to -$52.9 million in 2023, then skyrocketed by 70.36% to -$15.7 million in 2024, then slumped by 138.42% to -$14.1 million in 2025.
  • Its last three reported values are -$14.1 million in Q3 2025, -$4.2 million for Q2 2025, and $13.1 million during Q1 2025.